Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BofA, UBS Turn Bullish On This Online Recruitment Platform

BofA analyst Evgeny Annenkov upgraded HeadHunter Group PLC (NASDAQ:HHR) to Buy from Neutral and raised the price target to $85 (an upside of 55%),…
byAkanksha Bakshi
November 30, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • BofA analyst Evgeny Annenkov upgraded HeadHunter Group PLC (NASDAQ:HHR) to Buy from Neutral and raised the price target to $85 (an upside of 55%), from $52.
  • Annenkov mentions that the Russian labor market is expected to remain tight in the next five years, which should accelerate monetization for the company.
  • The analyst further notes that he sees a $2B addressable market for HeadHunter expected by 2024 vs. $200M that the company is expected to generate in domestic revenue this year.
  • Yesterday, UBS upgraded HeadHunter to Buy and announced a price target of $66, implying an upside of 20%.
  • Price Action: HHR shares are trading higher by 1.97% at $54.82 on the last check Tuesday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Abbott Announced Data at the American Diabetes Association Scientific Sessions Show Freestyle Libre 3 System Is First and Only 14-day Continuous Glucose Monitor System to Achieve a Mean Absolute Relative Difference of Less Than 8%

By Charles Gross
Today, 4:59 AM
Abbott (NYSE: ABT) today announced late-breaking clinical data that demonstrate the FreeStyle Libre® 3 system has an overall mean absolute relative difference (MARD) of 7.9%,1 making it the first and only 14-day continuous glucose monitoring (CGM) system to achieve a sub-8% overall MARD.

ABT